Image

Global Gene Therapy Market - Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Upcoming Report
  • Sep 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Gene Therapy Market, By Type (Somatic Gene Therapy, Germline Gene Therapy and Others), Gene Type (Antigen, Cytokine, Suicide and Others), Viral Vector (Retroviruses, Herpes Simplex Virus, Adenoviruses and Others), Non-Viral Vector (Naked or Plasmid Vectors, Electroporation and Others), Application (Oncology, Rare Diseases, Infectious Disease and Others), End Users (Hospitals, Homecare, Specialty Clinics and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy and Others), and Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of the Middle East and Africa) Industry Trends and Forecast to 2028

Gene Therapy Market Market Analysis and Insights : Global Gene Therapy Market

The gene therapy market is expected to witness market growth at a rate of 24.1% in the forecast period of 2021 to 2028. Data Bridge Market Research report on the gene therapy market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the arena of advanced therapies and gene delivery technologies is escalating the growth of the gene therapy market.

Gene therapy is known to be a method of insertion of genes into tissues and cells for treatment of any kind of disease. In this procedure the defective gene is substituted with a functional gene. It is the strategy of manipulation of expression of certain genes as the cause for the disease. This treatment is an encouraging therapy option for a number of diseases.

Major factors that are expected to boost the growth of the gene therapy market in the forecast period are the rise in the incidence of cancer. Furthermore, the struggle amongst the major pharmaceutical companies in the support of gene therapy products is further anticipated to propel the growth of the gene therapy market. On the other hand, the rise in the price regarding the therapy is further projected to impede the growth of the gene therapy market in the timeline period.

In addition, the rise in the investment of private and government organization in the research and development will further provide potential opportunities for the growth of the gene therapy market in the coming years. However, the dangerous effects such as undesirable immune responses might further challenge the growth of the gene therapy market in the near future.

The gene therapy market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the gene therapy market scenario, contact Data bridge market research for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.

Global Gene Therapy Market Scope and Market Size

The gene therapy market is segmented on the basis of type, gene type, viral vector, non-viral vector, application, end users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the gene therapy market is segmented into somatic gene therapy, germline gene therapy and others.
  • On the basis of gene type, the gene therapy market is segmented into antigen, cytokine, suicide and others.
  • On the basis of viral vector, the gene therapy market is segmented into retroviruses, herpes simplex virus, adenoviruses and others.
  • On the basis of non-viral vector, the gene therapy market is segmented into naked or plasmid vectors, electroporation and others.
  • On the basis of application, the gene therapy market is segmented into oncology, rare diseases, infectious disease, others.
  • On the basis of end users, the gene therapy market is segmented into hospitals, homecare, specialty clinics and others.
  • On the basis of distribution channel, the gene therapy market is segmented into hospital pharmacy, online pharmacy, retail pharmacy and others.

Gene Therapy Market Country Level Analysis

The gene therapy market is analyzed, and market size information is provided by country, type, gene type, viral vector, non-viral vector, application, end users and distribution channel as referenced above.

The countries covered in the gene therapy market report are the U.S., Canada, and Mexico in North America, Peru, Brazil, Argentina, and the rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA).

North America dominates the gene therapy market due to the sturdy regulatory framework for promoting the development of cellular therapy. Furthermore, the occurrence of significant number of biopharma companies will further boost the growth of the gene therapy market in the region during the forecast period. Europe is projected to observe significant amount of growth in the gene therapy market due to the rise in the acceptance of unique treatment options.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The gene therapy market also provides you with detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to the market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Gene Therapy Market Share Analysis

The gene therapy market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to the gene therapy market.

The major players covered in the gene therapy market report are Pfizer Inc., Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Spark Therapeutics, Inc., bluebird bio, Inc., Allergan plc, Krystal Biotech, Inc., Amicus Therapeutics, Inc., Sarepta Therapeutics, Novartis AG, MeiraGTx Limited, Rocket Pharmaceuticals, Lonza, Biogen, Gilead Sciences, Inc., REGENXBIO Inc., uniQure N.V., Solid Biosciences Inc. and Audentes Therapeutics among other domestic and global players. The gene therapy market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC), and the Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Global Gene Therapy Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions